Disease: Hereditary ATTR amyloidosis
- 2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis
- A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- A Comprehensive Multidisciplinary Diagnostic Algorithm for the Early and Efficient Detection of Amyloidosis
- A Novel Approach to Cardiac Magnetic Resonance Scar Characterization in Patients Affected by Cardiac Amyloidosis: A Pilot Study
- A rare variant in the TTR gene (p.E112K) is associated with systemic amyloidosis and a new symptom - skin hyperemia in response to ethanol intake: family segregation analysis, literature review, and a clinical case. Case report
- Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review
- Amyloidosis
- An ultra performance liquid chromatography method for transthyretin variants screening and heart failure assisting diagnosis
- Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model
- ATTR Gene Variants in HCM
- Biochemical and biophysical properties of a rare TTRA81V mutation causing mild transthyretin amyloid cardiomyopathy
- Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv)
- Cardiac [(99m)Tc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?
- Cardiac [<sup>99m</sup>Tc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?
- Cardiac Amyloid Quantification UsingĀ <sup>124</sup>I-Evuzamitide (<sup>124</sup>I-P5+14) Versus <sup>18</sup>F-Florbetapir: A Pilot PET/CT Study
- Cardiac amyloidosis: state-of-the-art review
- Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters
- Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis
- Case Report: Transthyretin Glu54Leu-a rare mutation with predominant cardiac phenotype
- Changes in Exercise Tolerance over Time in Patients with Transthyretin Amyloidosis Cardiomyopathy Treated with Tafamidis
- Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells
- Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis
- Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
- Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy
- Clinical differences between transthyretin cardiac amyloidosis and hypertensive heart disease
- Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study
- Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
- Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals
- Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy
- Data-independent acquisition mass spectrometry reveals comprehensive plasma protein profiles in the natural history of patients with hereditary transthyretin amyloidosis (ATTRv)
- Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
- Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers
- Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the Polish Cardiac Society
- Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis
- Diagnostics of cardiac amyloidosis
- Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two Cases
- Drug Repositioning for Amyloid Transthyretin Amyloidosis by Interactome Network Corrected by Graph Neural Networks and Transcriptome Analysis
- Effect of patisiran on stroke volume in hereditary transthyretin-mediated amyloidosis: insights from pressure-volume analysis of the APOLLO study
- Efficacy of Tafamidis in Patients with Ala97Ser Hereditary Transthyretin Cardiac Amyloidosis: A Six-Month Follow-Up Study
- Emerging Therapies for Transthyretin Amyloidosis
- Epidemiological study of the subtype frequency of systemic amyloidosis listed in the Annual of the Pathological Autopsy Cases in Japan
- Eplontersen: First Approval
- Exploring Transthyretin Amyloid Cardiomyopathy: A Comprehensive Review of the Disease and Upcoming Treatments
- Failure to Confirm Typical Echocardiographic Findings of Cardiac Amyloidosis in an Unresolved Nonischemic Cardiomyopathy Associated With Smoldering Multiple Myeloma: A Case Report
- First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant
- Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation
- Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
- Health-related quality of life among transthyretin amyloid cardiomyopathy patients
- Hereditary transthyretin amyloidosis presenting with spontaneous periorbital purpura: a case report
- Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy
- Identification of a novel transthyretin mutation D39Y in a cardiac amyloidosis patient and its biochemical characterizations
- Importance of genetic study in elderly patients with transthyretin cardiac amyloidosis
- Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases
- Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis
- Lessons from the first-in-human in vivo CRISPR/Cas9 editing of the TTR gene by NTLA-2001 trial in patients with transthyretin amyloidosis with cardiomyopathy
- Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria
- Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis
- Musculoskeletal Amyloidosis Imaging
- Musculoskeletal co-morbidities in patients with transthyretin amyloid cardiomyopathy: a systematic review
- Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review
- Neurofilament light chain as a biomarker for monitoring response to change in treatment in hereditary ATTR amyloidosis
- Neurological manifestations of ATTR amyloidosis
- Non-Cardiac Amyloidosis Findings Are Not Increased in African American Carriers of TTR V142I with Heart Failure and/or Arrhythmia
- Ophthalmological involvement in wild-type transthyretin amyloidosis: A multimodal imaging study
- Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal
- Patisiran
- Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis
- Patisiran, an RNAi therapeutic for hereditary transthyretin-mediated amyloidosis: Sub-analysis in Taiwanese patients from the APOLLO study
- Persistent Heart Failure Despite Medical Therapy Leading to a Diagnosis of Cardiac Amyloidosis
- Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
- Phenotypes Associated With the Val122Ile, Leu58His, and Late-Onset Val30Met Variants in Patients With Hereditary Transthyretin Amyloidosis
- Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry
- Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy
- Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients
- Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis
- Randall-Type Monoclonal Immunoglobulin Deposition Disease in Bone Scintigraphy
- Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States
- Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure
- Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy
- Red Flags Suggesting Cardiac Transthyretin Amyloidosis (ATTR) in Clinical Practice
- Reduction in (99m)Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathy
- Reduction in <sup>99m</sup>Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathy
- Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin
- RNA Interference and Neuromuscular Diseases: A Focus on Hereditary Transthyretin Amyloidosis
- RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis
- RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease
- Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice
- Strong positive light chain immunostaining in a patient with transthyretin amyloidosis
- Structures and Dynamics of beta-Rich Oligomers of ATTR (105-115) Assembly
- Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study
- Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis
- Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
- The genetic and clinical spectrum in a cohort of 39 families with complex inherited peripheral neuropathies
- Therapeutic Strategies for Hereditary Transthyretin Amyloidosis
- Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials
- Trends in diagnosis of cardiac transthyretin amyloidosis: 3-year analysis of scintigraphic studies: Prevalence of myocardial uptake and its predictor factors
- Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review
- Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease
- World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)